Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients

Clinical trial NCT01202591 · COMPLETED

Trial details

NCT number: NCT01202591
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

FGFR Inhibition, Pharmacokinetics, Biomarkers ER+ Breast Cancer

Start date: 2010-12-01
Primary completion: 2014-09-01
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.